Literature DB >> 16291082

Pleurovenous shunt in treating refractory nonmalignant hepatic hydrothorax: a case report.

Damrong Hadsaitong1, Wudthichai Suttithawil.   

Abstract

We report a case of successful, long-term pleurovenous shunt (PVS) in treating refractory nonmalignant hepatic hydrothorax. An 82-year-old woman with liver cirrhosis, hypertension complicated with chronic renal failure while on hemodialysis, presented with progressive dyspnea in association with a recurrent right-sided pleural effusion, occurring secondary to transdiaphragmatic migration of ascites. The diagnosis was established by a demonstration of (99m)Tc-sulphur colloid sequential scintigraphic scan. Despite repetitive thoracenteses and traditional medical treatment, she suffered dyspnea without relief. Denver peritoneovenous shunt was inserted into the right-sided pleural cavity to drain effusion into the subclavian vein without short- and long-term complications. Manually pumping schedule of 10 min was performed twice daily to remove pleural fluid into the venous circulation for maintaining shunt patency. After 19 months of follow-up, the patient is doing well and PVS remains patent without significant pleural effusion. PVS opens a window of opportunity and offers an alternative procedure with minimal invasiveness for high-risk patients with refractory hepatic hydrothorax. It could be an alternative treatment to other conventional surgical interventions.

Entities:  

Mesh:

Year:  2005        PMID: 16291082     DOI: 10.1016/j.rmed.2005.03.027

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

Review 1.  Hepatic Hydrothorax: An Updated Review on a Challenging Disease.

Authors:  Toufic Chaaban; Nadim Kanj; Imad Bou Akl
Journal:  Lung       Date:  2019-05-25       Impact factor: 2.584

2.  Complications of denver shunt.

Authors:  Eranga Perera; Shweta Bhatt; Vikram S Dogra
Journal:  J Clin Imaging Sci       Date:  2011-01-08

Review 3.  Pleurovenous Shunt Placement for the Management of Nonmalignant Pleural Effusion.

Authors:  Andy Awwad; Zach Berman; Jeet Minocha
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.